semaglutide eligibility across all current indications for us adults Most viewed this week from JAMA Internal Medicine: 50 mg of oral # daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian with overweight or # GLP-1 Drugs Can Be Used

(2010) Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India

Sleep: Prioritize 79 hours of quality sleep to support cellular repair processes and optimize mitochondrial turnover through autophagy

The histopathological features of pSS primarily manifest as lymphocytic infiltration and immune-complex deposition (2)

Liraglutide may not be as strong, but it works for specific kinds of patients

Source : NEJM SURMOUNT-1 Trial Over 90% achieved 5%+ weight loss 9 out of 10 participants lost at least 5% of their body weight using GLP-1 + GIP a powerful early milestone toward long-term success

Research shows Mounjaro leads to an average weight loss of around 26% after one year